cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
-
Contact Email
-
Phone
-
Journal Mail Official
-
Editorial Address
-
Location
Kota malang,
Jawa timur
INDONESIA
MNJ (Malang Neurology Journal)
Published by Universitas Brawijaya
ISSN : 24076724     EISSN : 24425001     DOI : -
Core Subject : Science,
Neuroscience
Malang Neurology Journal is a peer-reviewed and open access journal that focuses on promoting neurological sciences generated from basic neurosciences and clinical neurology. This journal publishes original articles, reviews, and also interesting case reports. Brief communications containing short features of medicine, latest developments in diagnostic procedures of neurology disease, treatment, or other health issues related to neurology that is important also acceptable. Letters and commentaries of our published articles are welcome.
Arjuna Subject : -
Articles 22 Documents
 1   2   3 
Search results for , issue "Vol. 10 No. 2 (2024): July" : 22 Documents clear
THE OUTCOME OF COGNITIVE THERAPY IN PATIENTS WITH FIRST-EVER STROKE AND RECURRENT STROKE Rianawati, Sri Budhi; Wardani, Rachmawati
MNJ (Malang Neurology Journal) Vol. 10 No. 2 (2024): July
Publisher : PERDOSSI (Perhimpunan Dokter Spesialis Saraf Indonesia Cabang Malang) - Indonesian Neurological Association Branch of Malang cooperated with Neurology Residency Program, Faculty of Medicine Brawijaya University, Malang, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mnj.2024.010.02.20

Abstract

Background: Vascular dementia (VaD) is the second most prevalent type of dementia that impacts elderly adults, succeeding Alzheimer's disease. In contrast to Alzheimer's disease, Vascular Dementia (VaD) presents a wide range of cognitive changes, which are greatly influenced by the specific neural regions that are impacted by vascular pathology. The incidence of dementia in adults with a prior history of stroke is 30%, demonstrating a frequency that is 3-5 times more than those without any discernible stroke-related impairments. In addition, the intensity or frequency of strokes may contribute to a decrease in cognitive reserve in persons with vascular dementia. Case Report: We presented two cases of VaD. The first case was a 62-year-old man with a history of ischemic stroke without sequelae a year before the complaints of frequent forgetfulness and cognitive impairment. Neuropsychological examination showed neurocognitive disturbances in orientation, attention, memory, and visuospatial domain with impaired daily activities function. The MRI result showed senile brain atrophy with chronic infarction on the right temporoparietooccipital lobe, left side mesencephalon, right side pons accompanied by cortical laminar necrosis on the right frontal lobe and left temporoparietal lobe. The second case was a 79-year-old man with history of recurrent ischemic stroke (three times since 2021-2022) with sequelae of left hemiparesis and complaints of frequent forgetfulness and cognitive impairment in the last 1 year. Neuropsychological examination showed neurocognitive disturbances in orientation, attention, and visuospatial domain with impaired daily activities function. The MRI result showed subacute multiple lacunar infarctions in right insular cortex, right frontotemporal lobe cortex, right corona radiata, with multiple chronic infarcts on the right frontotemporoparietal lobe, right corona radiata, right internal genu capsule, right lateral periventricular anterior horn, pons, right left cerebellum, also senile brain atrophy. Both patients were diagnosed as VaD and given donepezil 1x10mg and memantine 1x5mg to treat the cognitive impairment. Both cases showed improvements after 6 months of therapy with MMSE from 17 to 28, MoCA-INA from 12 to 22 and MMSE from 19 to 23, MoCA-INA from 14 to 21 respectively. Discussion: The probability of acquiring vascular dementia (VaD) was strongly associated with the incidence and frequency of strokes. The prevalence of newly developed dementia after the initial stroke is approximately 10%, which increases to 30% with recurrent strokes. The likelihood of experiencing cognitive impairment and dementia after a stroke is primarily determined by the specific attributes of the stroke. While pharmacological therapy largely focuses on cognitive impairment, other factors, such as the stroke's characteristics, might contribute to neuronal and molecular abnormalities that result in cognitive loss. Two instances were shown, both demonstrating enhancements, with the initial instance, involving primary strokes, exhibiting a superior outcome compared to the subsequent instance with recurring strokes. A more profound or recurring stroke has the potential to reduce cognitive reserve, hence potentially heightening vulnerability to neurodegenerative disorders, either directly or by means of modifications in social contacts or lifestyle, which can subsequently affect cognitive performance. Conclusion: Recurrent stroke plays a role in reducing cognitive reserve and increasing the risk of dementia. Patients with VaD have shorter life expectancy, thus the severity of VaD is best managed by providing optimum acute stroke care and recurrent stroke prevention.
NEUROMUSCULAR ELECTRICAL STIMULATION EFFECT ON WRIST SPASTICITY AND FUNCTION IN POST-STROKE PATIENT WITH UPPER EXTREMITY RECOVERY EXERCISE Setianto, Catur Ari; Syahrir, Ahmad; Ridwan, Mochammad
MNJ (Malang Neurology Journal) Vol. 10 No. 2 (2024): July
Publisher : PERDOSSI (Perhimpunan Dokter Spesialis Saraf Indonesia Cabang Malang) - Indonesian Neurological Association Branch of Malang cooperated with Neurology Residency Program, Faculty of Medicine Brawijaya University, Malang, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mnj.2024.010.02.09

Abstract

Background : Stroke is still a major health problem in the world and cause disability. Spasticity is one of the disability problems in stroke patients, which is more common in the wrist muscles. Recovery of spasticity is quite difficult and there is no definitive treatment that can speed up the recovery. Electrical stimulation is one of the rehabilitation intervensions that is believed to be able to recover spasticity based on neuroplasticity theory. There has been no consensus for the method of electrical stimulation that can give rise to optimal effects in stroke patients. New studies are still needed to determine effective therapeutic programs. Objective : The study aims to determine the effectiveness of the use of Wrist Neuromuscular Electrical Stimulation (NMES) against the recovery of spasticity and functional degrees of post-stroke patients who receive upper extremity recovery exercise (URE). Methods : The study used a randomized controlled trial. The study sample was stroke patients who are treated at dr. Saiful Anwar hospital policlinic. The study involved 30 post-stroke patients who were randomized into NMES combined with URE groups (15 patients) and URE groups (15 patients). Modified Asworth Scale and Fugl-Meyer Assesment of Upper Extremity total were measured before and after interventions. Modified Asworth Scale (MAS) is a scale than use for measure spasticity degree and have very good realibility. Fugl-Meyer Assesment Scaletha (FMA) is a scale for measure fungsionality of extremities which also have good realibility. Neuromuscular Electrical Stimulation (NMES) device is BTL-5000 series. Results : NMES combined with URE can reduce the degree of spasticity and increase the functional degree of the wrist in post-stroke patients significantly (p<0.05). URE can also significantly reduce the degree of spasticity and increase the functional degree of the wrist (p<0.05). NMES compared to URE futher reduced the degree of spasticity and increased the functional degree of the wrist in post-stroke patients insignificantly (p>0.05). Conclusion : The mean decrease in the degree of spasticity and increase in functional degree in the NMES group combined with URE measured by MAS scale showing that degree of spasticity with sig 0,101 > alpha (0,05) is not significant, but the mean decrease MAS in the NMES with URE group is bigger than group URE alone. The mean decrease in the degree of spasticity and increase in functional degree in the NMES group combined with URE measured by FMA scale showing that degree of spasticity with sig 0,787 > alpha (0,05) is also not significant, but the mean decrease FMA in the NMES with URE group is bigger than URE alone. This results mean that there is a significant score decrease in spasticity and increase of fungsionality degree before and after URE grop and there is not significant different score using NMES and URE group in MAS and FMA scale.

Page 3 of 3 | Total Record : 22

 1   2   3 

Filter by Year

2024 2024


Reset
Filter By Issues
All Issue Vol. 12 No. 1 (2026): January Vol. 11 No. 2 (2025): July Vol. 11 No. 1 (2025): January Vol. 10 No. 2 (2024): July Vol. 10 No. 1 (2024): January Vol. 9 No. 2 (2023): July Vol. 9 No. 1 (2023): January Vol. 8 No. 2 (2022): July Vol. 8 No. 1 (2022): January Vol. 7 No. 2 (2021): July Vol. 7 No. 1 (2021): January Vol. 6 No. 2 (2020): July Vol 6, No 1 (2020): January Vol 5, No 2 (2019): July Vol 5, No 1 (2019): January Vol 5, No 1 (2019): January Vol 4, No 2 (2018): July Vol 4, No 1 (2018): January Vol 4, No 1 (2018): January Vol 3, No 2 (2017): July Vol 3, No 1 (2017): January Vol 2, No 2 (2016): July Vol 2, No 2 (2016): July Vol 2, No 1 (2016): January Vol 2, No 1 (2016): January Vol 1, No 2 (2015): July Vol 1, No 1 (2015): January More Issue